Skip to main content
. Author manuscript; available in PMC: 2020 Nov 20.
Published in final edited form as: Nature. 2020 May 20;582(7811):265–270. doi: 10.1038/s41586-020-2311-z

Extended Data Fig. 4 |. Site-specific characterization of resolved IgE glycans from non-atopic and allergic individuals.

Extended Data Fig. 4 |

a, Occupancy of N-linked glycosylation sites; N140 (non-atopic n = 15, allergic n = 13), N168 (n = 16, 14), N218 (n = 15, 15), N265 (n = 12, 15), N371 (n = 15, 15), N383 (n = 16, 15), N394 (n = 13, 16). b, Percentage of oligomannose moieties at N394 (n = 23, 18). c, Number of fucose residues; N140 (n = 15, 13), N168 (n = 15, 17), N218 (n = 15, 19), N265 (n = 12, 18), N371 (n = 15, 17). d, Number of biGlcNAc residues; N140 (n = 15, 13), N168 (n = 16, 17), N218 (n = 15, 19), N265 (n = 16, 20), N371 (n = 16, 17). e, Number of galactose residues; N140 (n = 15, 14), N168 (n = 15, 17), N218 (n = 15, 19), N265 (n = 12, 19), N371 (n = 15, 17). f, Number of sialic acid residues; N140 (n = 14, 13), N168 (n = 15, 13), N218 (n = 15, 17), N265 (n = 12, 19), N371 (n = 15, 17). Data plotted are mean ± s.e.m. P values determined by two-way ANOVA with Sidak’s multiple comparison test. n represents biologically independent serum samples (a-f).